Colon Cancer Screening and Surveillance in Inflammatory Bowel Disease

키워드

참고문헌 (76)

1. Amarender Singh Puri, "Epidemiology of Ulcerative Colitis in South Asia", Intestinal research, 11(4), pp.250~255 (2013), 대한장연구학회
2. Rhodes JM, "Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared", Trends Mol Med, 8, pp.10~16 (2002)
3. Farraye FA, "AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease", Gastroenterology, 138, pp.746~774 (2010)
4. Mattar MC, "Current management of inflammatory bowel disease and colorectal cancer", Gastrointest Cancer Res, 4, pp.53~61 (2011)
5. Eaden JA, "The risk of colorectal cancer in ulcerative colitis: a meta-analysis", Gut, 48, pp.526~535 (2001)
6. Rutter MD, "Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis", Gastroenterology, 130, pp.1030~1038 (2006)
7. Velayos FS, "Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies", Am J Gastroenterol, 100, pp.1345~1353 (2005)
8. Kim BJ, "Trends of ulcerative colitis-associated colorectal cancer in Korea: A KASID study", J Gastroenterol Hepatol, 24, pp.667~671 (2009)
9. Itzkowitz SH, "Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation", Am J Physiol Gastrointest Liver Physiol, 287, pp.G7~G17 (2004)
10. Rutter M, "Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis", Gastroenterology, 126, pp.451~459 (2004)
11. Ekbom A, "Ulcerative colitis and colorectal cancer. A population-based study", N Engl J Med, 323, pp.1228~1233 (1990)
12. 김은영, "A Case of Cholangiocarcinoma and Colorectal Cancer Diagnosed Simultaneously in a Patient with Ulcerative Colitis and Concurrent Primary Sclerosing Cholangitis", Intestinal research, 10(4), pp.392~396 (2012), 대한장연구학회
13. Kornfeld D, "Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study", Gut, 41, pp.522~525 (1997)
14. Soetikno RM, "Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis", Gastrointest Endosc, 56, pp.48~54 (2002)
15. Broomé U, "Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer", Semin Liver Dis, 26, pp.31~41 (2006)
16. Delaunoit T, "Colorectal cancer prognosis among patients with inflammatory bowel disease", Clin Gastroenterol Hepatol, 4, pp.335~342 (2006)
17. Xie J, "Cancer in inflammatory bowel disease", World J Gastroenterol, 14, pp.378~389 (2008)
18. Peyrin-Biroulet L, "Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008)", Inflamm Bowel Dis, 18, pp.2247~2251 (2012)
19. Jensen AB, "Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study", Am J Gastroenterol, 101, pp.1283~1287 (2006)
20. Larsen M, "Survival after colorectal cancer in patients with Crohn’s disease: a nationwide population-based Danish follow-up study", Am J Gastroenterol, 102, pp.163~167 (2007)
21. Shu X, "Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden", Inflamm Bowel Dis, 17, pp.816~822 (2011)
22. Herrinton LJ, "Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010", Gastroenterology, 143, pp.382~389 (2012)
23. Collins PD, "Strategies for detecting colon cancer and", or dysplasia in patients with inflammatory bowel disease, 2006, pp.(2), CD000279~
24. Lutgens MW, "Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease", Br J Cancer, 101, pp.1671~1675 (2009)
25. Farraye FA, "AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease", Gastroenterology, 138, pp.738~745 (2010)
26. Kornbluth A, "Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee", Am J Gastroenterol, 92, pp.204~211 (1997)
27. Leighton JA, "ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease", Gastrointest Endosc, 63, pp.558~565 (2006)
28. Eaden JA, "British Society for Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease", Gut, 51(Suppl 5), pp.V10~V12 (2002)
29. Cairns SR, "Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)", Gut, 59, pp.666~689 (2010)
30. Itzkowitz SH, "Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease", Inflamm Bowel Dis, 11, pp.314~321 (2005)
31. Kornbluth A, "Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee", Am J Gastroenterol, 99, pp.1371~1385 (2004)
32. Biancone L, "European evidence-based consensus on the management of ulcerative colitis: special situations", J Crohns Colitis, 2, pp.63~92 (2008)
33. Ye BD, "Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea", Inflamm Bowel Dis, 17, pp.1901~1906 (2011)
34. Aarnio M, "Prognosis of colorectal cancer varies in different high-risk conditions", Ann Med, 30, pp.75~80 (1998)
35. Sugita A, "Survival with colorectal cancer in ulcerative colitis. A study of 102 cases", Ann Surg, 218, pp.189~195 (1993)
36. Itzkowitz SH, "Diagnosis and management of dysplasia in patients with inflammatory bowel diseases", Gastroenterology, 126, pp.1634~1648 (2004)
37. Hurlstone DP, "Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation", Endoscopy, 37, pp.1186~1192 (2005)
38. Kiesslich R, "Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis", Gastroenterology, 124, pp.880~888 (2003)
39. Kiesslich R, "Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis", Gastroenterology, 132, pp.874~882 (2007)
40. Marion JF, "Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial", Am J Gastroenterol, 103, pp.2342~2349 (2008)
41. Rutter MD, "Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis", Gut, 53, pp.256~260 (2004)
42. Hurlstone DP, "Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis", Gut, 57, pp.196~204 (2008)
43. Riddell RH, "Grading of dysplasia", Eur J Cancer, 31A, pp.1169~1170 (1995)
44. Blackstone MO, "Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy", Gastroenterology, 80, pp.366~374 (1981)
45. Ullman T, "Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis", Gastroenterology, 125, pp.1311~1319 (2003)
46. Befrits R, "Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study", Dis Colon Rectum, 45, pp.615~620 (2002)
47. Odze RD, "Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis", Clin Gastroenterol Hepatol, 2, pp.534~541 (2004)
48. Riddell RH, "Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications", Hum Pathol, 14, pp.931~968 (1983)
49. Torres C, "Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients", Am J Surg Pathol, 22, pp.275~284 (1998)
50. Farraye FA, "Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study", Gastrointest Endosc, 66, pp.519~529 (2007)
51. Rutter MD, "Most dysplasia in ulcerative colitis is visible at colonoscopy", Gastrointest Endosc, 60, pp.334~339 (2004)
52. Stolfi C, "Molecular basis of the potential of mesalazine to prevent colorectal cancer", World J Gastroenterol, 14, pp.4434~4439 (2008)
53. Allgayer H, "Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease", Aliment Pharmacol Ther, 18(Suppl 2), pp.10~14 (2003)
54. Lyakhovich A, "Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine", Aliment Pharmacol Ther, 31, pp.202~209 (2010)
55. Moody GA, "Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire", Eur J Gastroenterol Hepatol, 8, pp.1179~1183 (1996)
56. Pinczowski D, "Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study", Gastroenterology, 107, pp.117~120 (1994)
57. Nguyen GC, "5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations", Am J Gastroenterol, 107, pp.1298~1304 (2012)
58. van Staa TP, "5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study", Gut, 54, pp.1573~1578 (2005)
59. Eaden J, "Colorectal cancer prevention in ulcerative colitis: a case-control study", Aliment Pharmacol Ther, 14, pp.145~153 (2000)
60. Ullman T, "Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine", Clin Gastroenterol Hepatol, 6, pp.1225~1230 (2008)
61. Terdiman JP, "5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease", Inflamm Bowel Dis, 13, pp.367~371 (2007)
62. Bernstein CN, "Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?", Am J Gastroenterol, 98, pp.2784~2788 (2003)
63. 최창환, "궤양성 대장염 치료 가이드라인", Intestinal research, 10(1), pp.1~25 (2012), 대한장연구학회
64. Sebastian S, "Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I)", J Crohns Colitis, 8, pp.5~18 (2014)
65. Shetty K, "The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis", Am J Gastroenterol, 94, pp.1643~1649 (1999)
66. Hansen JD, "Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis", Dig Dis Sci, 58, pp.3079~3087 (2013)
67. Matula S, "Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine", Clin Gastroenterol Hepatol, 3, pp.1015~1021 (2005)
68. Lashner BA, "Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study", Gastroenterology, 97, pp.255~259 (1989)
69. Actis GC, "The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis", Biomed Pharmacother, 63, pp.362~365 (2009)
70. Actis GC, "Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast", Inflamm Allergy Drug Targets, 9, pp.6~9 (2010)
71. Baars JE, "The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study", Am J Gastroenterol, 106, pp.319~328 (2011)
72. Kandiel A, "Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine", Gut, 54, pp.1121~1125 (2005)
73. Kim YJ, "Prevention of colitis-associated carcinogenesis with infliximab", Cancer Prev Res (Phila), 3, pp.1314~1333 (2010)
74. Lashner BA, "Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis", Gastroenterology, 112, pp.29~32 (1997)
75. Biasco G, "Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis", Cancer Epidemiol Biomarkers Prev, 6, pp.469~471 (1997)
76. Poynter JN, "Statins and the risk of colorectal cancer", N Engl J Med, 352, pp.2184~2192 (2005)

관련 논문AI추천